HomeSPRINT • STO
add
Sprint Bioscience AB
Previous close
kr 1.59
Day range
kr 1.46 - kr 1.61
Year range
kr 0.76 - kr 2.25
Market cap
106.83M SEK
Avg Volume
52.52K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 14.80M | -62.58% |
Operating expense | 13.46M | 22.56% |
Net income | -5.21M | -118.20% |
Net profit margin | -35.19 | -148.65% |
Earnings per share | — | — |
EBITDA | -5.09M | -118.92% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 31.72M | -42.40% |
Total assets | 46.02M | -27.82% |
Total liabilities | 32.54M | 5.14% |
Total equity | 13.48M | — |
Shares outstanding | 69.82M | — |
Price to book | 8.35 | — |
Return on assets | -28.76% | — |
Return on capital | -84.31% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -5.21M | -118.20% |
Cash from operations | -4.29M | -110.83% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -4.29M | -110.83% |
Free cash flow | -2.60M | -109.38% |
About
Founded
2009
Website
Employees
36
